PETOSKEY, Mich., Sept. 20, 2018 /PRNewswire-PRWeb/ -- Design firm IXu announces a new multi-year contract with leading global condom manufacturer HLL Lifecare Ltd., the government-owned medical device enterprise of India, for marketing the VA "worn-of-women" line of condoms. Initial European sales begin in November, with pre-market orders available now online at ixullc.com.
The VA w.o.w brand, includes both the basic model and the media-hyped VA Vibe model with User Study 100% orgasm rate. Plans for an early 2019 FDA approval process will open U.S. distribution.
"Our new partnership with HLL Lifecare provides the VA an invaluable world-wide reach now, putting our successfully trial-marketed VA worn-of-women condom in the hands of any woman," stated IXu CEO Brian Osterberg.
"Looking forward for a mutually beneficial and longterm business relationship," stated Dr. Unnikrishnan.S.M., Associate Vice President, International Business at HLL.
HLL provides VA brand manufacturing for both retail and non-profit sectors. Distributor Clinifar of Portugal looks to supply the CE Mark-approved VA throughout Europe where previous trial-markets were very successful in national health clinics.
"The VA worn-of-women condom line will feature prominently in a new global line-of-defense against an increasing incidence of STI's," stated fertility expert Dr. Gregory Rosen, MD of Los Angeles, IXu's Medical Advisor.
IXu successfully lobbied the FDA in 2017 with help from Michigan Senator Debbie Stabenow, insisting the FDA take action to reclassify the female condom, allowing simple access to the markets.
IXu also distributes its latest world #1-rated inSpiral male condom model to all global markets, after relocating manufacturing to Indus Medicare Ltd. of India.
SOURCE IXu
The VA w.o.w brand, includes both the basic model and the media-hyped VA Vibe model with User Study 100% orgasm rate. Plans for an early 2019 FDA approval process will open U.S. distribution.
"Our new partnership with HLL Lifecare provides the VA an invaluable world-wide reach now, putting our successfully trial-marketed VA worn-of-women condom in the hands of any woman," stated IXu CEO Brian Osterberg.
"Looking forward for a mutually beneficial and longterm business relationship," stated Dr. Unnikrishnan.S.M., Associate Vice President, International Business at HLL.
HLL provides VA brand manufacturing for both retail and non-profit sectors. Distributor Clinifar of Portugal looks to supply the CE Mark-approved VA throughout Europe where previous trial-markets were very successful in national health clinics.
"The VA worn-of-women condom line will feature prominently in a new global line-of-defense against an increasing incidence of STI's," stated fertility expert Dr. Gregory Rosen, MD of Los Angeles, IXu's Medical Advisor.
IXu successfully lobbied the FDA in 2017 with help from Michigan Senator Debbie Stabenow, insisting the FDA take action to reclassify the female condom, allowing simple access to the markets.
IXu also distributes its latest world #1-rated inSpiral male condom model to all global markets, after relocating manufacturing to Indus Medicare Ltd. of India.
SOURCE IXu
